About
With 14 million people in the UK – around 21,000 per constituency – affected by continence issues, we came together to support patients by driving innovation, ensuring product quality, and safeguarding patient choice.
The Urology Trade Association was set up in 2007 with the primary aim to protect and promote the Drug Tariff as the most effective mechanism to support research, innovation and development within the urology industry. Having successfully secured this objective, the UTA has since expanded its remit to address a broader range of issues affecting the sector. Today, the urology industry represents one of the largest suppliers of health products to NHS patients.
Demand for urological products is expected to rise significantly over the next decade, driven by the UK’s ageing population and the increased prevalence of bladder and bowel conditions associated with older age.
What we do
The UTA meets and engages with several stakeholders and partners from across the Government, Parliament, the NHS and other regulatory bodies to highlight the major challenges and opportunities to be found in the urological sector.
The UTA supports the principle that clinicians should be able to prescribe, and patients to access, the medical device that is most clinically appropriate for their needs and preferences. By also increasing education amongst patients and the public about bladder and bowel issues, and the correct use of urological devices, the UTA helps ensuring that patients receive the best possible care while maintaining efficiency within the NHS system.
Whitehouse Communications acts as Secretariat for, and provides public affairs to, the Urology Trade Association.
Recent topics
Review of Part IX: UTA supported Members in engaging with core teams within the Department of Health and Social Care (DHSC) over the reform of Part IX of the Drug Tariff, highlighting key impacts of changes on patients, the wider NHS healthcare system and industry.
Value-Based Procurement: UTA members engaged with DHSC, NHS England and other stakeholders while they developed a value-based procurement methodology, ensuring that patients and benefits to the wider NHS system stayed at the core of the methodology.
NICE Late-Stage Assessments: UTA supported members in engaging with NICE during their recent Late Stage Assessments for products, including intermittent catheters.
Members
Bob Russell
Director of Governmental Affairs & Market Access, UK & Ireland, Hollister
Hannah Gagen
Head of Government Affairs and Patient Advocacy
Coloplast
Kim Taylor
Director and General Manager
Manfred Sauer
Alan Cook
Marketing Manager
Wellspect
Liz Hughes
Consultant
Class Medical
Deb Chapman
Consultant
CliniSupplies
Suzanne Thoms
Managing Director
Convatec
Jeremy Taylor
Sales Director
Bullen
Jonathan Scott
Head of Healthcare Policy
Salts Healthcare
Peak Medical
Jane Graham
Sales Manager
CliniMed
Barry Kaighin
Founder and Managing Director
Nephrostomy UK
Secretariat
Whitehouse Communications provides Secretariat services for the Urology Trade Association. For all queries relating to the Urology Trade Association and its members, please send these directly to the Secretariat.
Chris Whitehouse
Chair
Lavinia Troiani
Secretariat
Kaya Gadhia
Secretariat
Sophia Mencarelli
Secretariat
Member organisations
